|
Volumn 13, Issue 3, 1995, Pages 86-91
|
Biomedical and biotechnological applications of PEG- and PM-modified proteins
a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
BIOMEDICAL ENGINEERING;
BIOTECHNOLOGY;
CHEMICAL MODIFICATION;
DERIVATIVES;
DISEASES;
DRUG THERAPY;
IMMUNOLOGY;
MEDICAL APPLICATIONS;
MOLECULAR PHYSICS;
ORGANIC SOLVENTS;
POLYETHYLENE GLYCOLS;
SOLUBILITY;
BIOSTABILITY;
BIOTRANSFORMATION PROCESS;
IMMUNOREACTIVITY;
MOLECULAR PROPERTIES;
ORGANIC SYNTHESIS;
THERAPEUTIC PROTEINS;
PROTEINS;
ALBUMIN;
ANTIBIOTIC AGENT;
ASPARAGINASE;
BILIRUBIN OXIDASE;
CATALASE;
FETUIN;
GULONOLACTONE OXIDASE;
HEMOGLOBIN;
HIRUDIN;
IMMUNOGLOBULIN;
INTERLEUKIN 2;
MACROGOL;
MYOGLOBIN;
OVALBUMIN;
PEPTIDE;
PROTEIN A;
PROTEINASE;
PROTEINASE INHIBITOR;
PURINE NUCLEOSIDE PHOSPHORYLASE;
STREPTOKINASE;
SUPEROXIDE DISMUTASE;
THROMBIN;
TRYPSIN;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
URATE OXIDASE;
UROKINASE;
BIOTECHNOLOGY;
CEREBROSPINAL FLUID;
DRUG CLEARANCE;
DRUG DEVELOPMENT;
ENZYME ACTIVITY;
ENZYME STABILITY;
HUMAN;
IMMUNOREACTIVITY;
PRIORITY JOURNAL;
PROTEIN MODIFICATION;
REVIEW;
AMINO ACID SEQUENCE;
ASPARAGINASE;
BIOTECHNOLOGY;
DRUG DESIGN;
ENZYMES;
HUMAN;
IMMUNOCONJUGATES;
MOLECULAR SEQUENCE DATA;
POLYETHYLENE GLYCOLS;
PROTEINS;
SERUM ALBUMIN, BOVINE;
SOLUBILITY;
TECHNOLOGY, PHARMACEUTICAL;
|
EID: 0029256724
PISSN: 01677799
EISSN: None
Source Type: Journal
DOI: 10.1016/S0167-7799(00)88912-X Document Type: Article |
Times cited : (219)
|
References (58)
|